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ABSTRACT
Introduction: In Brazil, studies have shown that HTLV seroprevalence among pregnant 
women varies from 0 to 1.8%. However, this seroprevalence was unknown in the State of 
Pará, Brazil. The present study describes, for the first time, the HTLV seroprevalence among 
pregnant women from the State of Pará, Northern Brazil. Methods: 13,382 pregnant women 
were submitted to HTLV screening during prenatal care, and those with non-seronegative 
results to anti-HTLV were submitted to Western blot (WB) test to confirm and separate 
HTLV-1 and HTLV-2 carriers. Results: HTLV seroprevalence in the population of pregnant 
women was 0.3%, and HTLV-1 was identified in 95.3% of patients. The demographic profile of 
HTLV carriers was as follows: women with age between 20 and 40 years old (78.4%); residing 
in the metropolitan region of Belém, Pará (67.6%); and with educational level of high school 
(56.8%). Other variables related to infection were as follows: beginning of sexual intercourse 
between the age of 12 and 18 years old (64.9%) and have being breastfed for more than 6 
months (51.4%). Most of the women studied had at least two previous pregnancies (35.1%) 
and no abortion (70.3%). Coinfections (syphilis and HIV) were found in 10.8% (4/37) of 
these pregnant women. Conclusions: Seroprevalence of HTLV infection in pregnant women 
assisted in basic health units from the State of Pará, Northern Brazil, was 0.3% similar to those 
described in other Brazilian studies. The variables related to infection were important indicators 
in identifying pregnant women with a higher tendency to HTLV seropositivity, being a strategy 
for disease control and prevention, avoiding vertical transmission.
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RESUMO
Introdução: No Brasil, estudos mostram que a soroprevalência do HTLV entre gestantes 
varia de 0 a 1,8%. Contudo, esta soroprevalência era desconhecida no Estado do Pará, Brasil. 
O presente estudo descreve, pela primeira vez, a soroprevalência do HTLV entre gestantes do 
Estado do Pará, Norte do Brasil. Métodos: 13,382  gestantes foram submetidas à triagem para 
HTLV durante o pré-natal, e aquelas com sorologia alterada para anti-HTLV foram submetidas 
ao teste de Western Blot (WB), para confirmar e discriminar portadoras do HTLV-1 e do HTLV-
2. Resultados: A soroprevalência do HTLV na população de gestantes foi de 0,3%, sendo o 
HTLV-1 identificado em 95,3% das pacientes. O perfil demográfico das portadoras do HTLV 
foi de: mulheres com idade entre 20-40 anos (78,4%); residentes na região metropolitana 
de Belém (67,6%) e com nível educacional igual ao ensino médio (56,8%). Outras variáveis 
relacionadas à infecção foram: início das relações sexuais compreendido entre 12-18 anos 
(64,9%), e ter sido aleitada mais de 6 meses (51,4%). A maior parte das mulheres estudadas 
teve ao menos duas gestações anteriores (35,1%); e nenhum aborto (70,3%). Co-infecções 
(sífilis e HIV) foram descritas em 10,8% (4/37) das gestantes. A soroprevalência da infecção 
pelo HTLV em gestantes atendidas em Unidades Básicas de Saúde do Estado do Pará, 
Norte do Brasil foi de 0,3% semelhante à descrita em outros estudos brasileiros. As variáveis 
relacionadas com a infecção são indicadores importantes na identificação de gestantes com 
maior tendência a soropositividade pelo HTLV, sendo uma estratégia de controle e prevenção, 
evitando a transmissão vertical.
Palavras-chaves: HTLV. Gestantes. Soroprevalência.
Human T-lymphotropic virus types 1 and 2 
(HTLV-1 and HTLV-2) are human retroviruses 
with tropism for T-lymphocytes1. These HTLV 
types were described in the 1980s2, and in 2005, 
two other types have been described, HTLV-3 and 
HTLV-4, which are currently being investigated 
for molecular characterization and for a possible 
association with human disease3,4. The exact number 
of HTLV-1-seropositive individuals in the world is 
not known; it is estimated that approximately 15-20 
million people live with HTLV infection worldwide5. 
The seroprevalence rates differ according to the 
geographic area, socio-demographic composition of 
the population studied, and individual risk behaviors6 
associated with the dissemination of blood (injected 
drug use and blood transfusion) and other biological 
fluids exchanged during sexual relations (male-
to-female and female-to-male), as well as vertical 
(mother-to-child) transmission7. Mother-to-child 
transmission occurs in 20% of offspring from an 
infected mother, and it has been related to the 
mother’s proviral load, high antibody titers, and 
prolonged breastfeeding8,9. Postnatal infection by 
breastfeeding via human milk seems to play the 
most important role in vertical transmission10, and it 
may occur by means of breastfeeding by wet nurses 
or cross-breastfeeding (horizontal transmission)11. 
Few studies about vertical transmission were done, 
as well as the follow-up of exposed children during 
pregnancy, birth, and breastfeeding12-14.
Seroprevalence of HTLV infection was well 
described in the blood donors’ population and less 
documented in pregnant women population7,15,16. 
Brazilian studies reporting the seroprevalence of 
HTLV infection in pregnant women population 
described rates ranging from 0 to 1.8%17-22. In the 
State of Pará, seroprevalence of HTLV infection 
in pregnant women was unknown. Interventions 
to prevent vertical transmission and HTLV-related 
diseases include prenatal/neonatal screening in 
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TABLE 1 - Demographic data among pregnant HTLV-carriers in the State of 
Pará, Brazil.
Variable Number Percentage
Age (years) 
15-19 6 16.2
20-39 29 78.4
40-49 2 5.4
Local of residence 
Baixo Amazonas 2 5.4
Marajó 4 10.8
Belém metropolitan region 25 67.6
northeastern Pará 2 5.4
southeastern Pará 2 5.4
not informed 2 5.4
Educational level 
elementary school 5 13.5
high school 21 56.8
higher education 1 2.7
not informed 10 27.0
HTLV: human T-lymphotropic virus.
TABLE 2 - Sexual initiation and breastfeeding distribution among pregnant 
HTLV-carriers in the State of Pará, Brazil.
Variable Number Percentage 
Sexual initiation: age of first sexual intercourse (years)
<12  1 2.7
12-18 24 64.9
>18  6 16.2
not informed 6 16.2
Breastfeeding (months) 
<6 5 13.5
>6 19 51.4
not informed 4 10.8
HTLV: human T-lymphotropic virus.
geographic areas with high prevalence, and encouraging seropositive 
mothers to provide a milk formula rather than breast milk for their 
infants23,24, as approximately 1-5% of children infected through 
vertical transmission will develop ATL (adult T-cell leukemia)6. 
The aim of the present study was to describe HTLV seroprevalence 
and associated risk factors in pregnant women assisted in basic 
health units from Pará, Northern Brazil and to verify the presence of 
coinfection with Treponema pallidum (syphilis) and HIV.
Study design and patients’ selection criteria
The study was conducted from February to November of 2008 
through the program denominated Mother to Child, from the State 
Secretary of Public Health, whose main objective was to implement 
improvements in prenatal assistance in the region. During the mentioned 
period, 19 distinct municipalities joined the program, and 13,382 
pregnant women were interviewed during the prenatal care consultations 
performed in health care units. Serological tests for infectious agents, such 
as syphilis, HIV-1 and HIV-2, HTLV-1 and HTLV-2, cytomegalovirus, 
hepatitis B, hepatitis C, toxoplasmosis, and rubella, were made. 
Serological screening was performed by finger prick, and blood samples 
were collected through the dried blood spot (DBS) method.
Only pregnant women with an anti-HTLV reagent test (Murex 
HTLV-I+II, Dartford, England) were included in this study. 
The samples, which tested reactive in the screening test, were 
confirmed through Western blot (WB) test (HTLV-I/II, Gene Labs 
Diagnostics®).
Variables, such as age, local of residence, sexual behavior (number 
of sexual partners, age of first sexual intercourse), intravenous drug 
use, obstetric history (number of pregnancies, number of abortions), 
history of receiving blood transfusion, breastfeeding, syphilis, and 
HIV coinfections, were used to describe the epidemiological profile 
associated with HTLV infection. This information was obtained from 
a data bank from APAE/IDIPE (Association of Parents and Friends 
of Exceptional/Institute of Diagnostic, Research and Teaching).
Ethical considerations
The present study was approved by the ethics committee of  Pará 
State University (UEPA).
From the 13,382 pregnant women initially involved in this study, 
43 (0.3%) had an anti-HTLV reagent test result in the serological 
screening. This population represented the 10.7% of pregnant 
women who attended the public prenatal programs in the State of 
Pará, Brazil, in 2008.
WB test was used to confirm HTLV-1 and HTLV-2 infection: 
41 (95.3%) women were considered as HTLV positive (positive WB 
test); 39 (95.1%) pregnant women were positive to HTLV-1 and 
one (2.4%) to HTLV-2, and one had an indeterminate result in WB 
(2.4%). Among those 41 HTLV-carriers, 37 (90.2%) women had 
the epidemiological profile available related with HTLV infection. 
All those women were asymptomatic.
Demographic data revealed that the HTLV pregnant women 
detected in this study have ages ranging from 20 to 40 years old 
(mean age: 27.8±7.6 years old; 78.4%); educational level of high 
school (56.8%); and residing in the metropolitan region of Belém, 
the capital of the State of Pará (67.6%) (Table 1). Other variables 
more frequently detected with HTLV infection were the beginning 
of sexual intercourse between the age of 12 and 18 years old (64.9%) 
and being breastfed for more than 6 months (51.4%) (Table 2). 
Other variables, such as the use of intravenous drugs (2.7%), number 
of sexual partners (less than 3 partners; 29.7%), blood transfusion 
(8.1%), and coinfection (11%), were irrelevant to HTLV infection in 
this population of pregnant women. The distribution of pregnancies 
and abortions revealed that most part of the studied women had at 
least two previous pregnancies (35.1%) and no abortion (70.3%). 
Coinfection analysis revealed that from the 37 HTLV carriers with 
epidemiological data, three had a syphilis reagent test (8.1%), and 
one had an HIV reagent test (2.7%).
DISCUSSION
This is the first prevalence study of HTLV infection in the 
population of pregnant women from public prenatal programs in 
the State of Pará, Brazil. Our results indicated a seroprevalence of 
0.3% of HTLV infection. This seroprevalence was lower than those 
reported by Bittencourt and colleagues25 and Lima and Viana26, but 
higher than those reported by other authors18,22,27-31.
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The mean age observed among HTLV-positive pregnant women 
was similar to those described by other authors25,30. Onset of sexual 
activity between the age of 12 and 18 years old was a variable 
reported by a significant number of pregnant women (64.9%) with 
HTLV infection in this study. It was well-defined that male-to-female 
HTLV transmission occurs more frequently than female-to-male 
transmission32,33. When this biological factor is associated with a 
long time of sexual life, and/or multiple numbers of sexual partners, 
and/or non-use of condoms during sexual intercourse, the HTLV 
infection through sexual transmission seems to be more efficient.
Another variable related to HTLV infection was breastfeeding 
for more than 6 months. Studies have reported HTLV infection in 
mother's milk-fed infants several years after birth34, depending on 
the duration of feeding35,36. It is usually considered as a risk factor 
for HTLV infection with an exposure period higher than 6 months, 
which denominates the long-term breast-feeder. It represents a 
greater risk for acquiring HTLV infection, showing the necessity of 
the serological screening for HTLV infection among pregnant women 
during prenatal follow-up18.
Although the study design does not permit to clarify which was 
real via HTLV transmission in this population and the researchers 
were not able to exclude other routes of contamination, it has been 
shown that some variables were more related to HTLV infection in 
this population of pregnant women from Northern Brazil.
The HTLV-carrier women involved in this study were orientated 
about the possibility of HTLV vertical transmission. They were 
advised to avoid breastfeeding, and all of them received milk formula 
to feed their children. It is important to note that no one of these 
women knew about their infectious status. In parallel, the children 
who were born to these women were followed-up to investigate a 
possible vertical transmission.
Moreover, it is necessary to emphasize that this population 
represented only 10.7% of the pregnant women who attended the public 
prenatal care programs in the State of Pará, Brazil, in 2008. Therefore, it is 
expected that the absolute number of HTLV pregnant carriers is higher, 
thus, reinforcing the importance of identifying pregnant women with 
HTLV infection as a strategy to develop public health politics to control 
the disease and prevent its vertical transmission.
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